Market Overview:
The global disposable hemostatic agents market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of trauma and surgery, rising awareness about hemostatic agents, and technological advancements in disposable hemostatic agents. Based on type, the global disposable hemostatic agents market is segmented into gelation sponge, oxidized regenerated cellulose based hemostats, and others. Gelation sponge is expected to account for the largest share of the global disposable hemostatic agents market in 2018. This can be attributed to its easy availability and low cost as compared to other types of disposable hemostats.
Product Definition:
Disposable hemostatic agents are medical devices that are used to control or stop bleeding. They can be made from a variety of materials, including gauze, sponges, and pads. They are often used in conjunction with other medical devices, such as compression bandages and tourniquets. Disposable hemostatic agents are important for controlling bleeding during surgery and other medical procedures.
Gelation Sponge:
Gelation sponges are made from a gel-forming polymer and have high hemostatic properties. They can be used as an alternative to conventional sponges in certain applications such as in the preparation of heparin, fibrinolytic agents, and other blood products. Gelation sponges are also being studied for use in the treatment of various cardiovascular diseases due to their ability to regulate blood flow.
Oxidized Regenerated Cellulose Based Hemostats:
Oxidized regenerated cellulose (ORC) based hemostats are a group of highly effective agents used to prevent blood loss in surgical procedures. The product is made from the reaction of oxidized regenerated cellulose with hydrogen peroxide and it has been found to be an effective alternative for human plasma.
The product is currently under clinical investigation.
Application Insights:
Based on the application, the global disposable hemostatic agents market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high prevalence of chronic diseases such as trauma & burns, cardiovascular diseases and diabetes that require frequent monitoring and treatment procedures. As a result, demand for advanced diagnostics equipment has increased significantly over the past few years which drives product demand in this segment.
The other application segment includes surgeries or procedures that require direct attention to minimally invasive procedures with regard to vascular accesses or surgical intervention for diagnosis or treatment of acute conditions such as wounds & surgical sites bleeding disorders etcetera.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of developed healthcare infrastructure, high disposable income, and favorable reimbursement policies. The region is expected to maintain its dominance over the forecast period due to increasing awareness about various available treatment options and availability of advanced products.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism activities supported by low cost treatment in this region as compared with U.S., Canada, and European countries. In addition, growing penetration of international manufacturers such as Johnson & Johnson; Medtronic; Becton Dickinson & Company; Unilife Corporation; Stryker Corporation in this region will drive growth further. For instance, Unilife Corporation has entered into a distribution agreement with Takeda Pharmaceutical Co.
Growth Factors:
- Increasing incidence of traumatic injuries: The increasing incidence of traumatic injuries is one of the key growth drivers for the disposable hemostatic agents market. Traumatic injuries can cause severe bleeding, which can be effectively controlled by using disposable hemostatic agents.
- Growing demand for minimally invasive surgeries: Disposable hemostatic agents are increasingly being used in minimally invasive surgeries as they help in achieving haemostasis quickly and effectively. This is another key factor driving the growth of the disposable hemostatic agents market.
- Rising awareness about blood loss prevention: There is a growing awareness among healthcare professionals and patients about blood loss prevention techniques, which is fuelling the demand for disposable hemostatic agents worldwide.
- Technological advancements in disposable hemostats: The technological advancements in disposable hemostats are helping to improve their efficacy and safety profile, thereby driving their adoption across various applications segments globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Disposable Hemostatic Agents Market Research Report
By Type
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others
By Application
Hospital, Clinic, Other
By Companies
Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, Equimedical, Vascular Solutions, Z-Medica, BioCer Entwicklungs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Disposable Hemostatic Agents Market Report Segments:
The global Disposable Hemostatic Agents market is segmented on the basis of:
Types
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ethicon
- Pfizer
- Baxter International
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences
- Equimedical
- Vascular Solutions
- Z-Medica
- BioCer Entwicklungs
Highlights of The Disposable Hemostatic Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gelation Sponge
- Oxidized Regenerated Cellulose Based Hemostats
- Others
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Disposable Hemostatic Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Disposable hemostatic agents are medical devices that help stop bleeding by forming a clot. They come in different forms, including tablets, injections, and patches.
Some of the major players in the disposable hemostatic agents market are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, Equimedical, Vascular Solutions, Z-Medica, BioCer Entwicklungs.
The disposable hemostatic agents market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Disposable Hemostatic Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Disposable Hemostatic Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Disposable Hemostatic Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Disposable Hemostatic Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Disposable Hemostatic Agents Market Size & Forecast, 2020-2028
4.5.1 Disposable Hemostatic Agents Market Size and Y-o-Y Growth
4.5.2 Disposable Hemostatic Agents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Gelation Sponge
5.2.2 Oxidized Regenerated Cellulose Based Hemostats
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Disposable Hemostatic Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Disposable Hemostatic Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Gelation Sponge
9.6.2 Oxidized Regenerated Cellulose Based Hemostats
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Gelation Sponge
10.6.2 Oxidized Regenerated Cellulose Based Hemostats
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Gelation Sponge
11.6.2 Oxidized Regenerated Cellulose Based Hemostats
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Gelation Sponge
12.6.2 Oxidized Regenerated Cellulose Based Hemostats
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Gelation Sponge
13.6.2 Oxidized Regenerated Cellulose Based Hemostats
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Disposable Hemostatic Agents Market: Competitive Dashboard
14.2 Global Disposable Hemostatic Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ethicon
14.3.2 Pfizer
14.3.3 Baxter International
14.3.4 C. R. Bard
14.3.5 The Medicines Company
14.3.6 Anika Therapeutics
14.3.7 Advanced Medical Solutions
14.3.8 Integra LifeSciences
14.3.9 Equimedical
14.3.10 Vascular Solutions
14.3.11 Z-Medica
14.3.12 BioCer Entwicklungs
